WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011153049) METHODS AND USE OF COMPOUNDS THAT BIND TO HER2/NEU RECEPTOR COMPLEX
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/153049    International Application No.:    PCT/US2011/038042
Publication Date: 08.12.2011 International Filing Date: 26.05.2011
IPC:
A01N 57/00 (2006.01), A61K 31/66 (2006.01)
Applicants: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA [US/US]; 3160 Chestnut Street, Suite 200 Philadelphia, PA 19104-6283 (US) (For All Designated States Except US).
GREENE, Mark, I. [US/US]; (US) (For US Only).
MURALI, Ramachandran [US/US]; (US) (For US Only).
ZHANG, Hongtao [US/US]; (US) (For US Only)
Inventors: GREENE, Mark, I.; (US).
MURALI, Ramachandran; (US).
ZHANG, Hongtao; (US)
Agent: CALDWELL, John, W.; WOODCOCK WASHBURN LLP Cira Centre, 12th Floor 2929 Arch Street Philadelphia, PA 19104-2891 (US)
Priority Data:
61/350,652 02.06.2010 US
Title (EN) METHODS AND USE OF COMPOUNDS THAT BIND TO HER2/NEU RECEPTOR COMPLEX
(FR) PROCÉDÉS ET UTILISATION DE COMPOSÉS SE LIANT AU COMPLEXE RÉCEPTEUR HER2/NEU
Abstract: front page image
(EN)This application describes pharmaceutical compositions, kits, and methods for inhibiting cell proliferative disorders, especially those disorders characterized by overactivity and/or inappropriate activity of a receptor tyrosine kinase, including Her2 related cancers, and methods for imaging an Her-2 expressing tumor.
(FR)La présente demande de brevet concerne des compositions pharmaceutiques, des nécessaires et des méthodes permettant d'inhiber les troubles de la prolifération cellulaire et, en particulier, les troubles caractérisés par une suractivité et/ou une activité inadaptée d'un récepteur à activité tyrosine kinase, dont les cancers associés à Her2. L'invention concerne également des procédés d'imagerie d'une tumeur exprimant Her2.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)